The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Integrating Genetic Approaches into the Discovery of Anticancer Drugs
Abstract
The discovery of anticancer drugs is now driven by the numerous molecular alterations identified in tumor cells over the past decade. To exploit these alterations, it is necessary to understand how they define a molecular context that allows increased sensitivity to particular compounds. Traditional genetic approaches together with the new wealth of genomic information for both human and model organisms open up strategies by which drugs can be profiled for their ability to selectively kill cells in a molecular context that matches those found in tumors. Similarly, it may be possible to identify and validate new targets for drugs that would selectively kill tumor cells with a particular molecular context. This article outlines some of the ways that yeast genetics can be used to streamline anticancer drug discovery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Friedberg, E. C., Walker, G. C., Siede, W., Wood, R. D., Schultz, R. A., & Ellenberger, T. (2005) · doi:10.1128/9781555816704 · Cited by 5,683
Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379
Lessons from hereditary colorectal cancer
Kinzler, K. W., & Vogelstein, B. (1996) · Cell · doi:10.1016/s0092-8674(00)81333-1 · Cited by 4,919
BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTER
Gottesman, M. M., & Pastan, I. (1993) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.62.070193.002125 · Cited by 3,568
Hartwell, L. H., & Kastan, M. B. (1994) · Science · doi:10.1126/science.7997877 · Cited by 2,535
Self-citationCell Cycle Checkpoints: Preventing an Identity Crisis
Elledge, S. J. (1996) · Science · doi:10.1126/science.274.5293.1664 · Cited by 2,039
Genetic instability in colorectal cancers
Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1997) · Nature · doi:10.1038/386623a0 · Cited by 1,986
Human Homolog of patched , a Candidate Gene for the Basal Cell Nevus Syndrome
Johnson, R. L., Rothman, A. L., Xie, J., Goodrich, L. V., Bare, J. W., Bonifas, J. M., Quinn, A. G., Myers, R. M., Cox, D. R., Epstein, E. H., et al. (1996) · Science · doi:10.1126/science.272.5268.1668 · Cited by 1,857
Association of BRCA1 with Rad51 in Mitotic and Meiotic Cells
Scully, R., Chen, J., Plug, A., Xiao, Y., Weaver, D., Feunteun, J., Ashley, T., & Livingston, D. M. (1997) · Cell · doi:10.1016/s0092-8674(00)81847-4 · Cited by 1,459
Allelotype of Colorectal Carcinomas
Vogelstein, B., Fearon, E. R., Kern, S. E., Hamilton, S. R., Preisinger, A. C., Nakamura, Y., & White, R. (1989) · Science · doi:10.1126/science.2565047 · Cited by 1,304
Expression of Multidrug Resistance Gene in Human Cancers
Goldstein, L. J., Galski, H., Fojo, A., Willingham, M., Lai, S.-L., Gazdar, A., Pirker, R., Green, A., Crist, W., Brodeur, G. M., et al. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.2.116 · Cited by 1,290
Hengartner, M. O., & Horvitz, H. R. (1994) · Cell · doi:10.1016/0092-8674(94)90506-1 · Cited by 1,167
Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2
Sharan, S. K., Morimatsu, M., Albrecht, U., Lim, D.-S., Regel, E., Dinh, C., Sands, A., Eichele, G., Hasty, P., & Bradley, A. (1997) · Nature · doi:10.1038/386804a0 · Cited by 1,072
Analysis of mismatch repair genes in hereditary non–polyposis colorectal cancer patients
Liu, B., Parsons, R., Papadopoulos, N., Nicolaides, N. C., Lynch, H. T., Watson, P., Jass, J. R., Dunlop, M., Wyllie, A., Peltomäki, P., et al. (1996) · Nature Medicine · doi:10.1038/nm0296-169 · Cited by 945
Porter, P. L., Malone, K. E., Heagerty, P. J., Alexander, G. M., Gatti, L. A., Firpo, E. J., Daling, J. R., & Roberts, J. M. (1997) · Nature Medicine · doi:10.1038/nm0297-222 · Cited by 901
Thymine-Thymine Dimer Bypass by Yeast DNA Polymerase ζ
Nelson, J. R., Lawrence, C. W., & Hinkle, D. C. (1996) · Science · doi:10.1126/science.272.5268.1646 · Cited by 654
Biochemistry and genetics of eukaryotic mismatch repair.
Kolodner, R. (1996) · Genes & Development · doi:10.1101/gad.10.12.1433 · Cited by 592
Deoxycytidyl transferase activity of yeast REV1 protein
Nelson, J. R., Lawrence, C. W., & Hinkle, D. C. (1996) · Nature · doi:10.1038/382729a0 · Cited by 572
Hunter, T. (1997) · Cell · doi:10.1016/s0092-8674(00)81872-3 · Cited by 550
Ataxia-telangiectasia and cellular responses to DNA damage.
Meyn, M. S. (1995) · PubMed · Cited by 415
Accelerated Aging and Nucleolar Fragmentation in Yeast sgs1 Mutants
Sinclair, D. A., Mills, K., & Guarente, L. (1997) · Science · doi:10.1126/science.277.5330.1313 · Cited by 401
Watt, P. M., Louis, E. J., Borts, R. H., & Hickson, I. D. (1995) · Cell · doi:10.1016/0092-8674(95)90335-6 · Cited by 399
Developmental Control of Cell Cycle Regulators: A Fly's Perspective
Edgar, B. A., & Lehner, C. F. (1996) · Science · doi:10.1126/science.274.5293.1646 · Cited by 388
Watt, P. M., Hickson, I. D., Borts, R. H., & Louis, E. J. (1996) · Genetics · doi:10.1093/genetics/144.3.935 · Cited by 380
The spindle assembly checkpoint
Rudner, A. D., & Murray, A. W. (1996) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(96)80077-9 · Cited by 365
Self-citationAt the heart of the budding yeast cell cycle
Nasmyth, K. (1996) · Trends in Genetics · doi:10.1016/0168-9525(96)10041-x · Cited by 357
Stewart, E. (1997) · The EMBO Journal · doi:10.1093/emboj/16.10.2682 · Cited by 350
Dirick, L., Böhm, T., & Nasmyth, K. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00162.x · Cited by 330
Bezzubova, O., Silbergleit, A., Yamaguchi-Iwai, Y., Takeda, S., & Buerstedde, J.-M. (1997) · Cell · doi:10.1016/s0092-8674(00)80198-1 · Cited by 277
Hari, K. L., Santerre, A., Sekelsky, J. J., McKim, K. S., Boyd, J. B., & Scott Hawley, R. (1995) · Cell · doi:10.1016/0092-8674(95)90478-6 · Cited by 277
Antisense oligonucleotides: towards clinical trials
Agrawal, S. (1996) · Trends in Biotechnology · doi:10.1016/0167-7799(96)10053-6 · Cited by 265
Pathway correcting DNA replication errors in Saccharomyces cerevisiae.
Morrison, A., Johnson, A. L., Johnston, L. H., & Sugino, A. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05790.x · Cited by 264
RBF, a novel RB-related gene that regulates E2F activity and interacts with cyclin E in Drosophila.
Du, W., Vidal, M., Xie, J. E., & Dyson, N. (1996) · Genes & Development · doi:10.1101/gad.10.10.1206 · Cited by 258
DNA double-strand breaks and the RAD50-RAD57 genes in Saccharomyces.
Game, J. C. (1993) · PubMed · Cited by 245
The ras oncogene--an important regulatory element in lower eucaryotic organisms
Gibbs, W. W., & Marshall, M. S. (1989) · Microbiological Reviews · doi:10.1128/mmbr.53.2.171-185.1989 · Cited by 205
A tiger behind many doors: multiple genetic pathways to malignant glioma
Louis, D. N., & Gusella, J. F. (1995) · Trends in Genetics · doi:10.1016/s0168-9525(00)89125-8 · Cited by 185
Myc and Max Homologs in Drosophila
Gallant, P., Shiio, Y., Cheng, P. F., Parkhurst, S. M., & Eisenman, R. N. (1996) · Science · doi:10.1126/science.274.5292.1523 · Cited by 178
TFIIH: a key component in multiple DNA transactions
Hoeijmakers, J. H. J., Egly, J.-M., & Vermeulen, W. (1996) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(96)90006-4 · Cited by 161
DNA helicases in inherited human disorders
Ellis, N. A. (1997) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(97)80149-9 · Cited by 158
DNA Repair capacity and cisplatin sensitivity of human testis tumour cells
Köberle, B., Grimaldi, K. A., Sunters, A., Hartley, J. A., Kèlland, L. R., & Masters, J. R. (1997) · International Journal of Cancer · Cited by 132
Double indemnity: p53, BRCA and cancer
Brugarolas, J., & Jacks, T. (1997) · Nature Medicine · doi:10.1038/nm0797-721 · Cited by 106
Finley, R. L., Thomas, B. J., Zipursky, S. L., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.7.3011 · Cited by 94
Jeggo, P. A., Caldecott, K. W., Pidsley, S. C., & Banks, G. R. (1989) · PubMed · Cited by 87
Control of cell cycle arrest by the Mec1sc/Rad3sp DNA structure checkpoint pathway
Carr, A. M. (1997) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(97)80115-3 · Cited by 87
O6-Methylguanine-DNA methyltransferase activity in human liver tumors
Isowa, G., Ishizaki, K., Sadamoto, T., Tanaka, K. O. I., Yamaoka, Y., Ozawa, K., & Ikenaga, M. (1991) · Carcinogenesis · doi:10.1093/carcin/12.7.1313 · Cited by 84
Silber, J. R., Blank, A., Bobola, M. S., Mueller, B. A., Kolstoe, D. D., Ojemann, G. A., & Berger, M. S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.14.6941 · Cited by 79
From DNA damage to cell cycle arrest and suicide: a budding yeast perspective
Lydall, D. A., & Weinert, T. A. (1996) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(96)90003-9 · Cited by 73
Ras pathways in Caenorhabditis elegans
Kayne, P. S., & Sternberg, P. W. (1995) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(95)90051-9 · Cited by 63
Mitoxantrone: A Review of its Pharmacological Properties and Use in Acute Nonlymphoblastic Leukaemia
Dunn, C. J., & Goa, K. L. (1996) · Drugs & Aging · doi:10.2165/00002512-199609020-00007 · Cited by 48
Ras-regulated signaling processes in Saccharomyces cerevisiae
Broach, J. R. (1991) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(05)80302-8 · Cited by 41
O6-Methylguanine-DNA methyltransferase activity in human tumors
Chen, J., Zhang, Y.-P., Wang, C., Sun, Y., Fujimoto, J., & Ikenaga, M. (1992) · Carcinogenesis · doi:10.1093/carcin/13.9.1503 · Cited by 41
Anti-gene therapy: the use of ribozymes to inhibit gene function
Couture, L. A., & Stinchcomb, D. T. (1996) · Trends in Genetics · doi:10.1016/s0168-9525(97)81398-4 · Cited by 40
Mechanisms of carcinogenesis and the mutant mouse
Williams, B. O., & Jacks, T. (1996) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(96)90012-x · Cited by 24
The use of dominant-negative mutations to elucidate signal transduction pathways in lymphocytes
Perlmutter, R. M., & Alberola‐Ila, J. (1996) · Current Opinion in Immunology · doi:10.1016/s0952-7915(96)80069-0 · Cited by 19
Learning about cancer genes through invertebrate genetics
Hoffmann, F. M., Sternberg, P. W., & Herskowitz, I. (1992) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(05)80320-x · Cited by 7
Cited by
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
Barbie, D. A., Tamayo, P., Boehm, J. S., Kim, S. Y., Moody, S. E., Dunn, I. F., Schinzel, A. C., Sandy, P., Meylan, E., Scholl, C., et al. (2009) · Nature · doi:10.1038/nature08460 · Cited by 3,890
Requirement for p53 and p21 to Sustain G 2 Arrest After DNA Damage
Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., & Vogelstein, B. (1998) · Science · doi:10.1126/science.282.5393.1497 · Cited by 2,803
Systematic Genetic Analysis with Ordered Arrays of Yeast Deletion Mutants
Tong, A. H. Y., Evangelista, M., Parsons, A. B., Xu, H., Bader, G. D., Pagé, N., Robinson, M., Raghibizadeh, S., Hogue, C. W. V., Bussey, H., et al. (2001) · Science · doi:10.1126/science.1065810 · Cited by 2,138
Yang, W. S., & Stockwell, B. R. (2008) · Chemistry & Biology · doi:10.1016/j.chembiol.2008.02.010 · Cited by 1,876
The DNA damage response and cancer therapy
Lord, C. J., & Ashworth, A. (2012) · Nature · doi:10.1038/nature10760 · Cited by 1,649
Metadata
- Authors
- Hartwell, L. H., Szankasi, P., Roberts, C. J., Murray, A. W., & Friend, S. H.
- Venue
- Science
- Published
- 1997-11-07
- Volume
- 278
- Issue
- 5340
- Pages
- 1064-1068
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2124156743
- Cited by
- 773
- References
- 56
- FWCI
- 17.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.